Zyvox

Type: Product
Name: Zyvox
First reported Sep 30 2014 - Updated Sep 30 2014 - 1 reports

Stock Update: Pfizer Inc (NYSE:PFE) – Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination Study

[Business Wire] – Pfizer Inc. and Kyowa Hakko Kirin , announced today that they have entered into an agreement to explore the therapeutic potential of the combination of PfizeRead more on this.Pfizer Inc. (PFE) , valued at $188.77B, started the session ... [Published Jutia Group - Sep 30 2014]
First reported Sep 28 2014 - Updated Sep 28 2014 - 1 reports

buy Zyvox no rx, Zyvox where to buy, Zyvox with no prescription

Order Zyvox NOW and get free pills!!!Zyvox (Synonyms: Linezolid)price for Zyvox... drug Zyvox, buy Zyvox cod, drug Zyvox pills! purchase canadian Zyvox, Zyvox in internet no script... Zyvox 600 mg cr overnight fed ex! Zyvox usp... Zyvox ds safety? buy ... [Published Student Village - Sep 28 2014]
Entities: Zyvox, Cheap, MasterCard Inc
First reported Sep 23 2014 - Updated Sep 23 2014 - 1 reports

Linezolid Contributes to “Clinical Success” in MRSA Pneumonia

Veterans with methicillin-resistant Staphylococcus aureus (MRSA) pneumonia who were treated with linezolid were 53% more likely to be discharged as “clinical successes,” according to researchers from... ... [Published Federal Practitioner - Sep 23 2014]
First reported Sep 23 2014 - Updated Sep 23 2014 - 1 reports

Antimicrobials

The present invention relates to novel phenyl oxazolidinone compounds of formula I, their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to ... [Published Free Patents Online - Sep 23 2014]
First reported Sep 21 2014 - Updated Sep 21 2014 - 1 reports

Update: Cellceutix Calls Out To President Obama About Brilacidin

, CTIX issued a bold press release about a new Executive Order relating to antibiotic resistance. The company expects top line data from the Brilacidin Phase 2b trial to be positive. The entire defensin-mimetic portfolio is expected to be supported by ... [Published Seeking Alpha - Sep 21 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Cubist makes Euro landfall with a $400M purse for antibiotics R

The antibiotics-focused Cubist Pharmaceuticals ($CBST) has opened up shop in Europe with a Swiss international headquarters, part of its plan to spend $400 million on infectious disease R&D this year and spotlight new treatments for global scourges.Cubist ... [Published FierceBiotech - Sep 19 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Dalbavancin or Oritavancin for Skin Infections

Dr. Boucher and colleagues reply: Núñez-Núñez and Rodríguez-Baño and Cormican raise questions about our study design and the location of treatment. The DISCOVER studies were designed in accordance with published treatment guidelines and regulatory guidance. ... [Published New England Journal of Medicine - Sep 18 2014]
First reported Sep 14 2014 - Updated Sep 14 2014 - 1 reports

Excess antibiotic use in hospitals creates $163 million in preventable costs

A new study indicates that unnecessary antibiotic use by hospitals costs tens of millions of dollars in potentially preventable healthcare costs. Unnecessary antibiotic use contributes to antibiotic resistance, which can mean that people who have had ... [Published Examiner.com - Sep 14 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 1 reports

Pipeline Analysis of Hospital Acquired Pneumonia Drugs 2014-2020: Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix

Research and Markets (http://www.researchandmarkets.com/research/r49n8b/pipeline_analysis) has announced the addition of the "Pipeline Analysis of Hospital Acquired Pneumonia Drugs - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, ... [Published Individual.com - Sep 10 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 1 reports

Stock Update (NYSE:PFE): Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

[Business Wire] – Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Geno Germano, Group President, Global Innovative Pharma Business, at the Morgan Stanley Global Healthcare Conference on Tuesday, September ... [Published Jutia Group - Sep 03 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Mifeprex kit is called as RU486 or pharmaceutical fetus removal

)Pressbox (Press Release) -25 August 2014, Dallas, Texas, USA, (http://daynighthealthcare.co/) : Therapeutic Abortion (brand name Mifeprex) is a type of right on time fetus removal brought about by the mixture of two pharmaceuticals, mifepristone and ... [Published Pressbox.co.uk - Aug 27 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Uganda: TB Drugs - Poor Countries Hanging By the Thread

By Racheal NinsiimaJulius Kiiza, 26, was like many youths his age a few years back. He loved to hang out and live a good life.Never in his wildest dreams did he think he was developing a virulent form of tuberculosis - the multi- drug resistant TB (MDR-TB). ... [Published AllAfrica.com - Aug 27 2014]
Entities: Drugs, Uganda, HIV/AIDS

Quotes

The original article from September 18, 2013 that this updates is titled "Interview With Leo Ehrlich, Cellceutix CEO Following Acquisition of Polymedix Assets."
"We are one of the few companies globally to take on the challenge of antibiotic resistance, and this expansion enables us to continue to address the growing medical need" Cubist Senior Vice President Patrick Vink said in a statement
Research and Markets (http://www.researchandmarkets.com/research/r49n8b/pipeline_analysis) has announced the addition of the "Pipeline Analysis of Hospital Acquired Pneumonia Drugs - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering...
"I would lose breath especially at night because of chest congestion" he said

More Content

All (22) | News (19) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Stock Update: Pfizer Inc (NYSE:PFE) – Pfizer An... [Published Jutia Group - Sep 30 2014]
purchas Desyrel, Desyrel order, Desyrel next da... [Published Student Village - Sep 28 2014]
buy Zyvox no rx, Zyvox where to buy, Zyvox with... [Published Student Village - Sep 28 2014]
Chloramphenicol to buy, generic Chloramphenicol... [Published Student Village - Sep 28 2014]
Linezolid Contributes to “Clinical Success” in ... [Published Federal Practitioner - Sep 23 2014]
Antimicrobials [Published Free Patents Online - Sep 23 2014]
Update: Cellceutix Calls Out To President Obama... [Published Seeking Alpha - Sep 21 2014]
Cubist makes Euro landfall with a $400M purse f... [Published FierceBiotech - Sep 19 2014]
Dalbavancin or Oritavancin for Skin Infections [Published New England Journal of Medicine - Sep 18 2014]
Excess antibiotic use in hospitals creates $163... [Published Examiner.com - Sep 14 2014]
11http://www.currencyonline.com/tbl/ 47924441 [Published Student Village - Sep 11 2014]
Pipeline Analysis of Hospital Acquired Pneumoni... [Published Individual.com - Sep 10 2014]
Stock Update (NYSE:PFE): Pfizer Invites Public ... [Published Jutia Group - Sep 03 2014]
Mifeprex kit is called as RU486 or pharmaceutic... [Published Pressbox.co.uk - Aug 27 2014]
Uganda: TB Drugs - Poor Countries Hanging By th... [Published AllAfrica.com - Aug 27 2014]
Oragenics: Interview With CEO Bonfiglio [Published Seeking Alpha - Aug 24 2014]
Pfizer net earnings dips by 79% in Q2 to $2,912... [Published PharmaBiz - Jul 30 2014]
7 Companies That Attempted to Silence Whistlebl... [Published Wall St. Cheat Sheet - Jun 19 2014]
Will Pfizer Try Again for AstraZeneca? [Published Wall St. Cheat Sheet - May 21 2014]
Despite Generic Vancomycin's Continued Dominanc... [Published PR Newswire: Health - May 06 2014]
Pfizer's Double Disappointment a Good Buying Op... [Published The Street Latest - May 05 2014]
The Zacks Analyst Blog Highlights:MannKind, Cub... [Published PR Newswire - Apr 10 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
7 Companies That Attempted to Silence Whistlebl... [Published Wall St. Cheat Sheet - Jun 19 2014]
Source: http://www.flickr.com/photos/stevendepolo/ Names like Daniel Ellsworth, Edward Snowden, and Julian Assange have become forever etched in the American lexicon. These individuals, along with troves of others, have single-handedly been able ...
Will Pfizer Try Again for AstraZeneca? [Published Wall St. Cheat Sheet - May 21 2014]
Source: Getty Images There is a misconception among investors that Pfizer ( NYSE:PFE ) was only trying to acquire AstraZeneca ( NYSE:AZN ) to gain access to a country with a corporate tax rate of 21 percent, far lower than the 35 percent rate ...
Despite Generic Vancomycin's Continued Dominanc... [Published PR Newswire: Health - May 06 2014]
BURLINGTON, Mass., May 6, 2014 /PRNewswire/ -- Decision Resources Group finds that overall, infectious disease (ID) specialists and non-ID physicians (critical care and internal medicine specialists) prefer the branded agents Cubist's Cubicin (daptomycin) ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.